BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1549 related articles for article (PubMed ID: 18001438)

  • 81. Presence of fetal DNA in maternal plasma decades after pregnancy.
    Invernizzi P; Biondi ML; Battezzati PM; Perego F; Selmi C; Cecchini F; Podda M; Simoni G
    Hum Genet; 2002 Jun; 110(6):587-91. PubMed ID: 12107445
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Noninvasive prenatal genetic diagnosis: a bioethical reflection on the use of noninvasive prenatal diagnosis from the analysis of nucleic acids present in maternal peripheral blood].
    González-Melado FJ; Di Pietro ML
    Cuad Bioet; 2011; 22(74):49-75. PubMed ID: 21692554
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cell-free fetal DNA in maternal blood: kinetics, source and structure.
    Bischoff FZ; Lewis DE; Simpson JL
    Hum Reprod Update; 2005; 11(1):59-67. PubMed ID: 15569699
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy.
    Hyett JA; Gardener G; Stojilkovic-Mikic T; Finning KM; Martin PG; Rodeck CH; Chitty LS
    Prenat Diagn; 2005 Dec; 25(12):1111-6. PubMed ID: 16231296
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternal blood.
    Sekizawa A; Watanabe A; Kimura T; Saito H; Yanaihara T; Sato T
    Obstet Gynecol; 1996 Apr; 87(4):501-5. PubMed ID: 8602298
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma--next step toward reliable non-invasive prenatal diagnostics.
    Zejskova L; Jancuskova T; Kotlabova K; Doucha J; Hromadnikova I
    Exp Mol Pathol; 2010 Dec; 89(3):241-7. PubMed ID: 20868679
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [A noninvasive approach to studying fetal cells for prenatal diagnosis of chromosomal aneuploidies].
    Zolotukhina TV; Shilova NV; Zamulaeva IA; Smirnova SG; Orlova NV; Saenko AS
    Genetika; 1999 Oct; 35(10):1422-30. PubMed ID: 10624587
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma.
    Ding C
    Methods Mol Biol; 2008; 444():253-67. PubMed ID: 18425487
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Non-invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound.
    Avent ND; Chitty LS
    Prenat Diagn; 2006 Jul; 26(7):598-603. PubMed ID: 16856214
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Expression of fetal epsilon and gamma globin gene in maternal peripheral blood].
    Xu T; Wang BY; Chen F; Zhang L; Duan WM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Feb; 24(2):127-9. PubMed ID: 12697115
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Study on fetal SRY gene in maternal plasma using nested polymerase chain reaction].
    Hong P; Zhu PY; Huang YF; Luan JF
    Zhonghua Nan Ke Xue; 2006 Apr; 12(4):333-6. PubMed ID: 16683567
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical potential for noninvasive prenatal diagnosis through detection of fetal cells in maternal blood.
    Purwosunu Y; Sekizawa A; Koide K; Okazaki S; Farina A; Okai T
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):10-20. PubMed ID: 17272202
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease.
    Chu T; Bunce K; Hogge WA; Peters DG
    Bioinformatics; 2009 May; 25(10):1244-50. PubMed ID: 19307238
    [TBL] [Abstract][Full Text] [Related]  

  • 95. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Genomic medicine in prenatal diagnosis.
    South ST; Chen Z; Brothman AR
    Clin Obstet Gynecol; 2008 Mar; 51(1):62-73. PubMed ID: 18303500
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Invasive procedures for prenatal diagnosis: any future left?
    Simpson JL
    Best Pract Res Clin Obstet Gynaecol; 2012 Oct; 26(5):625-38. PubMed ID: 22749621
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Enrichment of fetal cells and free fetal DNA from maternal blood: An insight into the Basel experience.
    Holzgreve W; Zhong XY; Burk MR; Hahn S
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):43-4. PubMed ID: 11753508
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Noninvasive prenatal diagnosis by analysis of fetal DNA in maternal plasma.
    Chiu RW; Lo YM
    Methods Mol Biol; 2006; 336():101-9. PubMed ID: 16916256
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art.
    Lo YM
    BJOG; 2009 Jan; 116(2):152-7. PubMed ID: 19076946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 78.